Unrivaled Expertise at the Convergence of Healthcare, Life Science, and AI.
We are a highly specialized venture fund committed to backing the next generation of platform companies that fundamentally transform healthcare economics and drug development. Our unique advantage is Founder-led technical and clinical diligence, ensuring capital flows only to solutions grounded in both transformative foundational technology and real-world patient necessity.
Unrivaled Authority:
The Founder Advantage
-
Deep Tech Engine: The most prolific inventor in AI Drug Discovery (5 U.S. Patents issued in 2025, 15 filed in 2025) and founder of Deep EigenMatics.
-
Unrivaled Academic Rigor: Holds an M.D. from Duke University and advanced degrees in both Mathematics and Computer Science.
-
Clinical & Regulatory Leader: Practicing Retina Specialist who led the largest U.S. clinical trial for an autonomous AI system and trained in the Nobel-winning Lefkowitz Lab.
-
Cybersecurity & Compliance: A Google Cloud Certified Cybersecurity Engineer and former Chair of the Medical Device Cybersecurity Summit.
Affiliate Companies
